Intensity modulated versus non-intensity modulated radiotherapy in the treatment of the left breast and upper internal mammary lymph node chain: a comparative planning study

被引:62
作者
Cho, BCJ
Hurkmans, CW
Damen, EMF
Zijpa, LJ
Mijnheer, BJ
机构
[1] Netherlands Canc Inst, Dept Radiotherapy, Antoni Van Leeuwenhoek Hosp, NL-1066 CX Amsterdam, Netherlands
[2] Cross Canc Inst, Dept Radiat Oncol, Edmonton, AB T6G 1Z2, Canada
关键词
three-dimensional treatment planning; intensity modulated radiotherapy; breast cancer; internal mammary lymph node; normal tissue complication probability;
D O I
10.1016/S0167-8140(01)00472-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and purpose: To compare and evaluate intensity modulated (IMRT) and non-intensity modulated radiotherapy techniques in the treatment of the left breast and upper internal mammary lymph node chain. Material and methods: The breast, upper internal mammary chain (IMC), heart and lungs were delineated on a computed tomography (CT)-scan for 12 patients. Three different treatment plans were created: (1) tangential photon fields with oblique IMC electron-photon fields with manually optimized beam weights and wedges, (2) wide split tangential photon fields with a heart block and computer optimized wedge angles, and (3) IMRT tangential photon fields. For the IMRT technique, an inverse planning program (KonRad) generated the intensity profiles and a clinical three-dimensional treatment planning system (U-Plan) optimized the segment weights. U-MPlan calculated the dose distribution for all three techniques. The normal tissue complication probabilities (NTCPs) for the organs at risk (ORs) were calculated for comparison. Results: The average root mean square deviation of the differential dose-volume histogram of the breast planning target volume was 4.6, 3.9 and 3.5% and the average mean dose to the IMC was 97.2, 108.0 and 99.6% for the oblique electron, wide split tangent and IMRT techniques, respectively. The average NTCP for the ORs (i.e. heart and lungs) were comparable between the oblique electron and IMRT techniques (less than or equal to0.7%). The wide split tangent technique resulted in hfgher NTCP values (greater than or equal to2%) for the ORs. Conclusions: The lowest NTCP values were found with the oblique electron and the IMRT techniques. The IMRT technique had the best breast and IMC target coverage. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:127 / 136
页数:10
相关论文
共 63 条
[1]  
ABE O, 1995, NEW ENGL J MED, V333, P1444
[2]   LONG-TERM EFFECT OF INTERNAL MAMMARY CHAIN TREATMENT - RESULTS OF A MULTIVARIATE-ANALYSIS OF 1195 PATIENTS WITH OPERABLE BREAST-CANCER AND POSITIVE AXILLARY NODES [J].
ARRIAGADA, R ;
LE, MG ;
MOURIESSE, H ;
FONTAINE, F ;
DEWAR, J ;
ROCHARD, F ;
SPIELMANN, M ;
LACOUR, J ;
TUBIANA, M ;
SARRAZIN, D .
RADIOTHERAPY AND ONCOLOGY, 1988, 11 (03) :213-222
[3]   Internal mammary node coverage: An investigation of presently accepted techniques [J].
Arthur, DW ;
Arnfield, MR ;
Warwicke, LA ;
Morris, MM ;
Zwicker, RD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :139-146
[4]  
BARTELINK H, 1996, 2292210925 EORTC
[5]   Modulated beam conformal therapy for head and neck tumors [J].
Boyer, AL ;
Geis, P ;
Grant, W ;
Carol, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (01) :227-236
[6]   Beam intensity modulation to reduce the field sizes for conformal irradiation of lung tumors: A dosimetric study [J].
Brugmans, MJP ;
van der Horst, A ;
Lebesque, JV ;
Mijnheer, BJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (04) :893-904
[7]  
Chao KSC, 2000, INT J CANCER, V90, P92, DOI 10.1002/(SICI)1097-0215(20000420)90:2<92::AID-IJC5>3.0.CO
[8]  
2-9
[9]  
CUZICK J, 1987, CANCER TREAT REP, V71, P15
[10]   CAUSE-SPECIFIC MORTALITY IN LONG-TERM SURVIVORS OF BREAST-CANCER WHO PARTICIPATED IN TRIALS OF RADIOTHERAPY [J].
CUZICK, J ;
STEWART, H ;
RUTQVIST, L ;
HOUGHTON, J ;
EDWARDS, R ;
REDMOND, C ;
PETO, R ;
BAUM, M ;
FISHER, B ;
HOST, H ;
LYTHGOE, J ;
RIBEIRO, G ;
SCHEURLEN, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (03) :447-453